|
Hepatocellular carcinoma: Risk factors, pattern of
presentation and outcome in a tertiary health facility
Akande Oladimeji Ajayi1*,
Ebenezer Adekunle Ajayi2 and Oluwole Akinwumi
Komolafe3
1Department
of Medicine, Federal Medical Centre, PMB 201, Ido-Ekiti,
Nigeria.
2Department
of Medicine, Federal Medical Centre,PMB 201, Ido-Ekiti,
Nigeria.
3Department
of Histopathology, Ladoke Akintola University Teaching
Hospital
Osogbo, Nigeria.
*Corresponding author. E-mail: dejiajayi2@yahoo.co.uk.
Tel: +234-803-447-6437.
Accepted 15 January 2009 |
|
Hepatocellular carcinoma is the fifth most common cancer in
the world. Its incidence is increasing worldwide ranging
between 3 and 9% annually. The aim of this study was to see
the pattern of clinical presentation, identify the possible
risk factors and the clinical outcome among HCC patients
presenting at our health facility. The case records of all
patients with histopathological diagnosis of HCC within the
study period June 2003-May 2008 were scrutinized.
Demographic, clinical presentation, investigations, risk
factors and outcome data were extracted. Data analysis was
done using the SPSS computer soft ware. Logistic regression
model was fitted to identify the impact of the various risk
factors on HCC. A total number of 53 patients with
histopathological diagnosis of HCC were registered. Their
ages ranged from 35 to 73 and mean age of 50±21.8 years.
Thirty seven (69.8%) were males while sixteen (30.2%) were
females giving M: F ratio of 2.31:1. The left lobe was
affected in 15.1% (8), right lobe in 22.6% (12) and both
lobes in 62.3% (33). 54.7% tested positive for HBsAg, 3.8%
were HCV-Ab positive. All the patients in this study
presented at an advanced stage of the disease. Aflatoxin
exposure, though not proven, because no test was done to
incriminate it, was highly suspected and could be a major
risk factor in this study; hence efforts need to be doubled
up as regards effective awareness campaigns, general health
/social education and food perseveration methods.
Key words: Hepatocellular carcinoma, aflatoxin,
hepatitis B and C. |